PharmaShots | Incisive News in 3 Shots

Subscribe Now

All Posts by Date

PharmaShots Weekly Snapshots (February 06 - 10, 2023)

PharmaShots Weekly Snapshots (February 06 - 10, 2023)

February 10, 2023

LEO Pharma Reports P-III Trial (DELTA 2) Results of Delgocitinib for Chronic Hand Eczema

LEO Pharma Reports P-III Trial (DELTA 2) Results of Delgocitinib for Chronic Hand Eczema

February 10, 2023

Samsung Bioepis Reports P-IV Study of SB4 (biosimilar, etanercept)

Samsung Bioepis Reports P-IV Study of SB4 (biosimilar, etanercept)

February 10, 2023

GSK’s Jemperli (dostarlimab-gxly) Receives the US FDA’s Regular Approval for Recurrent or Advanced Mismatch Repair-Deficient Endometrial Cancer

GSK’s Jemperli (dostarlimab-gxly) Receives the US FDA’s Regular Approval for Recurrent or Advanced Mismatch Repair-Deficient Endom...

February 10, 2023

Artios Initiates P-II Randomized Trial of ART0380 + Gemcitabine for Platinum Resistant Ovarian Cancer

Artios Initiates P-II Randomized Trial of ART0380 + Gemcitabine for Platinum Resistant Ovarian Cancer

February 10, 2023

Kura Oncology Reports First Patient Dosing of Ziftomenib in P-II (KOMET-001) Registration-Directed Trial for NPM1-Mutant Acute Myeloid Leukemia

Kura Oncology Reports First Patient Dosing of Ziftomenib in P-II (KOMET-001) Registration-Directed Trial for NPM1-Mutant Acute Mye...

February 10, 2023

Contact Us

First Floor, B 150, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
[email protected]
Newsletter

Our Information

Follow Us